Article Text

Download PDFPDF
Enumeration and immunohistochemical characterisation of bone marrow basophils in myeloproliferative disorders using the basophil specific monoclonal antibody 2D7
  1. H Agis1,
  2. M-T Krauth1,
  3. I Mosberger2,
  4. L Müllauer2,
  5. I Simonitsch-Klupp2,
  6. L B Schwartz3,
  7. D Printz4,
  8. A Böhm1,
  9. G Fritsch4,
  10. H-P Horny5,
  11. P Valent1
  1. 1Department of Internal Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Austria
  2. 2Department of Clinical Pathology, Medical University of Vienna
  3. 3Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology, Virginia Commonwealth University, Richmond, Virginia, USA
  4. 4Children’s Cancer Research Institute, St Anna Children’s Hospital, Vienna, Austria
  5. 5Department of Pathology, University of Lübeck, Germany
  1. Correspondence to:
    Dr Peter Valent
    Department of Internal Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria; peter.valent{at}


Background: Basophils are highly specialised granulocytes that express a unique profile of antigens and increase in myeloproliferative disorders (MPD). In chronic myeloid leukaemia (CML), basophilia is a diagnostic and prognostic determinant. So far, however, no reliable approach for routine detection and enumeration of bone marrow basophils has become available.

Objective: To detect and enumerate basophils in bone marrow sections in patients with CML and other MPD

Methods: The anti-basophil antibody 2D7 was applied to paraffin embedded bone marrow sections from normal/reactive subjects (n = 31), patients with CML (chronic phase, n = 37; accelerated phase, n = 9), and other MPD (chronic idiopathic myelofibrosis (CIMF), n = 20; polycythaemia vera (PV), n = 20; essential thrombocythaemia (ET), n = 20; indolent systemic mastocytosis (ISM), n = 7).

Results: As assessed by serial section staining, 2D7+ cells were found to co-express myeloperoxidase, histidine decarboxylase, CD9, and CD43, but did not express B cell or T cell restricted antigens. 2D7+ bone marrow cells were found to increase in CML compared with normal/reactive bone marrow and other MPD (median numbers of 2D7+ cells/mm2: CML, 33; normal/reactive bone marrow, 6; CIMF, 10; PV, 6; ET, 5; ISM, 3; p<0.05). The highest basophil counts were recorded in accelerated phase CML (115/mm2).

Conclusions: A novel immunohistochemical procedure has been established for basophil detection in normal bone marrow and MPD. This approach should help in the quantification of bone marrow basophils at diagnosis and during anti-leukaemic treatment.

  • CIMF, chronic idiopathic myelofibrosis
  • CML, chronic myeloid leukaemia
  • MPD, myeloproliferative disorder
  • VEGF, vascular endothelial growth factor
  • basophil
  • chronic myeloid leukaemia
  • immunohistochemistry
  • myeloproliferative diseases

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.